GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: A prospective randomized study (multiple letters) [3]

Human Reproduction

Volumn 20, Issue 11, 2005, Pages 3258-3260

  Engmann, Lawrence ^a   Benadiva, Claudio ^a   Humaidan, Peter ^b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b VIBORG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN ANTAGONIST; PROGESTERONE;

BIRTH RATE; CLINICAL TRIAL; DRUG EFFICACY; DRUG WITHDRAWAL; EMBRYO TRANSFER; FERTILIZATION IN VITRO; FETOPLACENTAL UNIT; GESTATIONAL AGE; HUMAN; INFERTILITY; INTRACYTOPLASMIC SPERM INJECTION; LETTER; LUTEAL PHASE; LUTEOLYSIS; NIDATION; OOCYTE MATURATION; OVARY DISEASE; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; PROSPECTIVE STUDY; SPONTANEOUS ABORTION;

EID: 27944468719     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei190     Document Type: Letter

References (0)